Trial intelligence / Profile preview

Anticoagulants in Stable PTCA

NCT00669149Phase 4Terminated

Sponsor
Centre Hospitalier de Pau
Start
Jun 2008
Primary completion
Aug 2013
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of heparin, enoxaparin, bivalirudin in coronary artery disease (CAD), sponsored by Centre Hospitalier de Pau. Started Jun 2008; status: terminated.

02

Drugs

heparinenoxaparinbivalirudin
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00669149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00669149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call